Get access

Chronic mucocutaneous candidiasis may cause elevated gliadin antibodies

Authors

  • Florian Brinkert,

    1. Department of Pediatrics, Pediatric Gastroenterology, Hepatology and Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Search for more papers by this author
  • Marijke Sornsakrin,

    1. Department of Pediatrics, Pediatric Gastroenterology, Hepatology and Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Search for more papers by this author
  • Dorothee Krebs-Schmitt,

    1. Department of Pediatrics, Pediatric Gastroenterology, Hepatology and Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Search for more papers by this author
  • Rainer Ganschow

    1. Department of Pediatrics, Pediatric Gastroenterology, Hepatology and Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Search for more papers by this author

Florian Brinkert, M.D., Department of Pediatrics, Pediatric Gastroenterology, Hepatology and Immunology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52,
20246 Hamburg, Germany.
Tel: +49-40-7410-5-4629 |
Fax: +49-40-7410-5-9444 |
Email: f.brinkert@uke.uni-hamburg.de

Abstract

We present a 4-year-old boy admitted to the hospital due to the typical symptoms of celiac disease with severe dystrophy, anaemia and elevated gliadin IgG antibodies. Upper endoscopy ruled out celiac disease but showed severe Candida esophagitis. Due to an impaired T-cell function especially following Candida antigen stimulation in vitro, plus recurrent Candida infections of the skin, the diagnosis of chronic mucocutaneous candidasis (CMC) was made. Under the treatment with fluconazol, trimethoprim/sulfmethoxazole and IVIG, the child improved impressively. Gliadin antibodies declined steadily.

Conclusion:  The common symptoms growth retardation, anaemia and elevated gliadin antibodies are suggestive for celiac disease but very unspecific. The rare immunodeficiency CMC may cause elevated gliadin antibodies.

Get access to the full text of this article

Ancillary